K2 Principal Fund’s Bristol-Myers Squibb BMY Stock Holding History

K2 Principal Fund’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,000	Closed	-$477K	–	285
2019 Q1	$477K	Buy	+10,000	New	+$498K	0.06%	231
2018 Q1	–	Sell	-630,000	Closed	-$38.6M	–	325
2017 Q4	$38.6M	Buy	630,000 +160,000	+34%	+$10M	2.79%	3
2017 Q3	$30M	Sell	470,000 -75,000	-14%	-$4.38M	1.98%	9
2017 Q2	$30.4M	Buy	545,000 +272,200	+100%	+$14.8M	2.01%	8
2017 Q1	$14.8M	Buy	272,800 +247,800	+991%	+$13.6M	1.23%	17
2016 Q4	$1.46M	Sell	25,000 -109,800	-81%	-$6M	0.14%	141
2016 Q3	$7.27M	Buy	+134,800	New	+$8.66M	0.82%	31

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

K2 Principal Fund's BMY Position: Q2 2019 in Review

K2 Principal Fund sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 10,000 shares — an estimated $477K sold.

K2 Principal Fund first reported a position in BMY in Q3 2016 and held it in 7 quarters. The position peaked at $14.5M in Q4 2017. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

K2 Principal Fund reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
K2 Principal Fund sold 10,000 Bristol-Myers Squibb shares in Q2 2019, an estimated $477K.
K2 Principal Fund first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 7 quarters.
K2 Principal Fund's Bristol-Myers Squibb position peaked at $14.5M in Q4 2017.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on K2 Principal Fund's 13F filing for Q2 2019, filed 14 Aug 2019.